Current and future roles of biochemical biomarkers in hypertrophic cardiomyopathy

被引：2
作者：
Dimitrow, Pawel Petkow [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Cardiol 2, Krakow, Poland
来源：
BIOMARKERS IN MEDICINE | 2014年 / 8卷 / 01期
关键词：
biomarker; hypertrophic cardiomyopathy; sudden death; COLD PRESSOR TEST; MYOCARDIAL FIBROSIS; SYMPTOMATIC PATIENTS; CORONARY VASOMOTION; MAGNETIC-RESONANCE; OXIDATIVE STRESS; DYSFUNCTION; SEVERITY; INFLAMMATION; VERAPAMIL;
D O I：
10.2217/bmm.13.119
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：81 / 83
页数：3
相关论文
共 50 条
  • [41] Plasma biomarkers of endothelial dysfunction in patients with hypertrophic cardiomyopathy
    Dimitrow, Pawel R.
    Undas, Anetta
    Bober, Maria
    Tracz, Wiestawa
    Dubiel, Jack S.
    PHARMACOLOGICAL REPORTS, 2007, 59 (06) : 715 - 720
  • [42] Hypertrophic Cardiomyopathy
    Dungu, Jason N.
    Hardy-Wallace, Amy
    Dimarco, Anthony D.
    Savage, Henry O.
    CURRENT HEART FAILURE REPORTS, 2024, 21 (04) : 428 - 438
  • [43] Hypertrophic cardiomyopathy
    Shah, Maully
    CARDIOLOGY IN THE YOUNG, 2017, 27 : S25 - S30
  • [44] Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
    Raj Murthi, Sarala
    Petry, Andreas
    Shashikadze, Bachuki
    Stoeckl, Jan B.
    Schmid, Manuel
    Santamaria, Gianluca
    Klingel, Karin
    Kracun, Damir
    Chen, Xinpei
    Bauer, Sabine
    Schmitt, Joachim P.
    Flenkenthaler, Florian
    Gorham, Josh
    Toepfer, Christopher N.
    Potesil, David
    Hruska, Pavel
    Zdrahal, Zbynek
    Mayer, Zsuzsanna
    Klop, Mathieu
    Lehmann, Luisa
    Qin, Yishi
    Papanakli, Laura
    Spielmann, Nadine
    Moretti, Alessandra
    Froehlich, Thomas
    Ewert, Peter
    Holdenrieder, Stefan
    Seidman, Jonathan G.
    Seidman, Christine E.
    Goerlach, Agnes
    Wolf, Cordula M.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] Hypertrophic Cardiomyopathy
    Geske, Jeffrey B.
    Ommen, Steve R.
    Gersh, Bernard J.
    JACC-HEART FAILURE, 2018, 6 (05) : 364 - 375
  • [46] Evaluation of potential novel biomarkers for feline hypertrophic cardiomyopathy
    Chong, Andrew
    Joshua, Jessica
    Raheb, Shari
    Pires, Ananda
    Colpitts, Michelle
    Caswell, Jeff L.
    Fonfara, Sonja
    RESEARCH IN VETERINARY SCIENCE, 2024, 180
  • [47] Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy
    Karabinowska-Malocha, Aleksandra
    Dziewiecka, Ewa
    Szymanska, Magdalena
    Banys, Pawel
    Urbanczyk-Zawadzka, Malgorzata
    Krupinski, Maciej
    Mielnik, Malgorzata
    Wisniowska-Smialek, Sylwia
    Podolec, Piotr
    Budkiewicz, Aleksandra
    Zydzik, Lukasz
    Wypasek, Ewa
    Rubis, Pawel
    KARDIOLOGIA POLSKA, 2023, 81 (7-8) : 692 - 699
  • [48] Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy
    Hao Cui
    Yifan Wang
    Xiumeng Hua
    Jing Han
    Han Mo
    Shun Liu
    Hongmei Wang
    Siyuan Huang
    Yiqi Zhao
    Xiao Chen
    Qian Zhao
    Hao Jia
    Yuan Chang
    Jiangping Song
    Biomarker Research, 13 (1)
  • [49] Prognosis in Hypertrophic Cardiomyopathy With Contrast-Enhanced Cardiac Magnetic Resonance The Future Looks Bright
    Salerno, Michael
    Kramer, Christopher M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (11) : 888 - 889
  • [50] Hypertrophic Cardiomyopathy
    Elijah R. Behr
    William J. McKenna
    Current Treatment Options in Cardiovascular Medicine, 2002, 4 (6) : 443 - 453
12345